Close

NewLink Genetics (NLNK) Unit Receives Prime BARDA Contract for Ebola Vaccine Manufacturing, Development (MRK)

December 22, 2014 8:03 AM EST Send to a Friend
NewLink Genetics (NASDAQ: NLNK) and Merck (NYSE: MRK) announced that the Biomedical Advanced Research and Development Authority (BARDA) of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login